METAvivor signed onto a letter supporting the Clinical Trial Modernization Act.
METAvivor has joined nearly 200 patient advocacy, public health, and health care organizations in supporting the bipartisan Clinical Trial Modernization Act.
This legislation would reduce cost and geographic barriers that prevent patients from enrolling and participating in clinical trials, making research more accessible for people facing serious diseases, including metastatic breast cancer.
Clinical trials are essential to advancing new treatments and improving outcomes. METAvivor is proud to support policies that expand equitable access to clinical research.
Click the button below to access the full letter.